Phase III Clinical Trial Vaccine: A Guide for Sponsors and CROs
Before a vaccine can receive regulatory approval and reach the public, it must pass through one final, rigorous checkpoint: Phase III clinical trials. This is the stage where the product’s safety, efficacy and overall impact on public health are thoroughly tested in large, diverse populations. For sponsors and CROs, Phase III trials represent a high-stakes, […]